JP2014515734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515734A5 JP2014515734A5 JP2013558302A JP2013558302A JP2014515734A5 JP 2014515734 A5 JP2014515734 A5 JP 2014515734A5 JP 2013558302 A JP2013558302 A JP 2013558302A JP 2013558302 A JP2013558302 A JP 2013558302A JP 2014515734 A5 JP2014515734 A5 JP 2014515734A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- hydrogen
- oso
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012453 solvate Substances 0.000 claims 31
- 229910052739 hydrogen Inorganic materials 0.000 claims 28
- 239000001257 hydrogen Substances 0.000 claims 28
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 28
- 150000003839 salts Chemical class 0.000 claims 26
- 239000002253 acid Substances 0.000 claims 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 18
- 229910052736 halogen Inorganic materials 0.000 claims 17
- 150000007513 acids Chemical class 0.000 claims 15
- 125000006267 biphenyl group Chemical group 0.000 claims 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 13
- 150000002367 halogens Chemical class 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 10
- 239000000126 substance Substances 0.000 claims 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 7
- 150000003254 radicals Chemical class 0.000 claims 7
- 150000001989 diazonium salts Chemical class 0.000 claims 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 4
- 150000001721 carbon Chemical group 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- -1 sulfooxy group Chemical group 0.000 claims 4
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical group O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 239000012954 diazonium Substances 0.000 claims 3
- 239000003163 gonadal steroid hormone Substances 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000005265 dialkylamine group Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000006193 diazotization reaction Methods 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical group [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 230000017074 necrotic cell death Effects 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000001550 testis Anatomy 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011014087 | 2011-03-16 | ||
| DE102011014087.5 | 2011-03-16 | ||
| PCT/DE2012/000258 WO2012122969A1 (de) | 2011-03-16 | 2012-03-12 | Substituierte diphenylderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014515734A JP2014515734A (ja) | 2014-07-03 |
| JP2014515734A5 true JP2014515734A5 (enExample) | 2015-03-12 |
Family
ID=46201039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558302A Pending JP2014515734A (ja) | 2011-03-16 | 2012-03-12 | 置換ジフェニル誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9409859B2 (enExample) |
| EP (1) | EP2686298B1 (enExample) |
| JP (1) | JP2014515734A (enExample) |
| KR (1) | KR20140011383A (enExample) |
| CN (1) | CN103492365A (enExample) |
| AU (1) | AU2012228755B2 (enExample) |
| BR (1) | BR112013023316B1 (enExample) |
| CA (1) | CA2829998C (enExample) |
| EA (1) | EA024381B1 (enExample) |
| ES (1) | ES2683306T3 (enExample) |
| IL (1) | IL228431A (enExample) |
| MX (1) | MX346097B (enExample) |
| SG (1) | SG193443A1 (enExample) |
| WO (1) | WO2012122969A1 (enExample) |
| ZA (1) | ZA201306794B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102015008631A1 (de) | 2014-10-30 | 2016-05-04 | Creative Therapeutics Gmbh | Arzneimittel für die Krebstherapie |
| CN109293661A (zh) * | 2018-10-22 | 2019-02-01 | 武汉华星光电半导体显示技术有限公司 | 近红外光热激活延迟荧光材料及其制备方法、显示装置 |
| DE102020125641A1 (de) | 2020-09-25 | 2022-03-31 | Creative Therapeutics Gmbh | Wirkstoffe und Arzneimittel für die Therapie von Viruserkrankungen, insbesondere Corona-Infektionen, insbesondere COVID-19 |
| CN115582027B (zh) * | 2022-09-09 | 2024-07-19 | 天津工业大学 | 一种不同长度烷基链修饰的共价有机框架有机溶剂纳滤膜制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2648660A (en) | 1953-08-11 | Process fob | ||
| GB691410A (en) * | 1950-03-25 | 1953-05-13 | Cfmc | Process for the preparation of diazoamino compounds and water-insoluble azodyestuffs on fibres |
| DE1793115A1 (de) | 1968-08-03 | 1972-02-03 | Bayer Ag | Neue Triazenderivate |
| BE789138A (fr) * | 1971-09-24 | 1973-03-22 | Bayer Ag | Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant |
| DE4334823C2 (de) | 1993-10-09 | 1998-09-17 | Schering Ag | Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen |
| DE10052333A1 (de) | 2000-10-24 | 2002-05-02 | Boehringer Ingelheim Pharma | Neue Sulfooxybenzamide |
| DE10324496A1 (de) | 2003-05-30 | 2004-12-16 | Bayer Healthcare Ag | Targetorientierte Chemotherapie von Tumoren der Sexualorgane |
| RS51189B (sr) | 2004-07-28 | 2010-10-31 | Janssen Pharmaceutica N.V. | Supstituisani derivati propenil piperazina kao novi inhibitori histonske deacetilaze |
| AR057579A1 (es) | 2005-11-23 | 2007-12-05 | Merck & Co Inc | Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac) |
| CA2656627A1 (en) | 2006-07-05 | 2008-01-10 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Sulfamatobenzothiophene derivatives |
| CN101796020A (zh) | 2007-07-04 | 2010-08-04 | 三N药品有限责任公司 | 用于癌症治疗的新型三氮烯化合物 |
-
2012
- 2012-03-12 EA EA201391335A patent/EA024381B1/ru not_active IP Right Cessation
- 2012-03-12 CN CN201280016088.5A patent/CN103492365A/zh active Pending
- 2012-03-12 CA CA2829998A patent/CA2829998C/en active Active
- 2012-03-12 EP EP12724856.5A patent/EP2686298B1/de active Active
- 2012-03-12 AU AU2012228755A patent/AU2012228755B2/en not_active Ceased
- 2012-03-12 BR BR112013023316-8A patent/BR112013023316B1/pt active IP Right Grant
- 2012-03-12 ES ES12724856.5T patent/ES2683306T3/es active Active
- 2012-03-12 US US14/005,395 patent/US9409859B2/en active Active
- 2012-03-12 MX MX2013010401A patent/MX346097B/es active IP Right Grant
- 2012-03-12 JP JP2013558302A patent/JP2014515734A/ja active Pending
- 2012-03-12 SG SG2013068911A patent/SG193443A1/en unknown
- 2012-03-12 KR KR1020137027073A patent/KR20140011383A/ko not_active Ceased
- 2012-03-12 WO PCT/DE2012/000258 patent/WO2012122969A1/de not_active Ceased
-
2013
- 2013-09-10 ZA ZA2013/06794A patent/ZA201306794B/en unknown
- 2013-09-15 IL IL228431A patent/IL228431A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6190025B2 (ja) | ジグリシドエーテル誘導体治療剤およびその使用方法 | |
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| RU2481345C2 (ru) | Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в области свертывания крови | |
| JP2014521688A5 (enExample) | ||
| JP2016503799A5 (enExample) | ||
| JP2019522055A5 (enExample) | ||
| JP2018524341A5 (enExample) | ||
| JP2011506588A5 (enExample) | ||
| JP2010523599A5 (enExample) | ||
| JP2014515734A5 (enExample) | ||
| RU2015125307A (ru) | Комбинированная терапия | |
| JP2011529054A5 (enExample) | ||
| RU2007102228A (ru) | Энантиоселективный способ получения производных хинолина | |
| JP2012504608A5 (enExample) | ||
| JP2012526086A5 (enExample) | ||
| JP2008510778A5 (enExample) | ||
| JP2017528415A5 (enExample) | ||
| WO2017049307A1 (en) | Carborane compounds and methods of use thereof | |
| JP2011500013A5 (enExample) | ||
| JP2017533203A5 (enExample) | ||
| JP2012509265A5 (enExample) | ||
| RU2012126112A (ru) | Соединение, некоторые его новые формы, фармацевтические композиции на его основе и способы получения и применения | |
| AU2025213600A1 (en) | Nurr1 receptor modulators | |
| JP7018514B2 (ja) | 化合物及びその薬学での応用 | |
| JP2009539822A5 (enExample) |